Referred to the House Committee on Energy and Commerce.
The bill gives the FDA expanded authorities and resources related to human foods, including research funding, advisory structures, and a center linking food and medicine.
It creates a competitive grant program, an Advisory Committee on Human Foods, a Human Foods Innovation Account concept, and a public-private partnership to study food-contact chemicals.
It exempts certain voluntary FDA research data collection from the Paperwork Reduction Act and requires processed-food manufacturers to provide recipe and nonlabeled-ingredient information to the FDA, with publication of contents of nondeclared ingredients.
Moderate-scope administrative fixes and research funding could clear committee, but mandatory recipe disclosures and funding needs lower enactment chance.
Relative to its intended legislative type, this bill is a substantive policy change that combines statutory amendments, program creation, and new operational duties for the FDA. It provides several concrete mechanisms (amendments to FD&C Act text, specified program areas, named responsible officials, and at least one reporting schedule) but leaves important fiscal, procedural, and confidentiality details to agency discretion or absent entirely.
Recordkeeping and disclosure of recipes versus trade-secret protections
Recordkeeping and disclosure of recipes versus trade-secret protections
Overall supportive.
The bill strengthens FDA research capacity, prioritizes infant and maternal nutrition, addresses ultra-processed foods, and targets chemical limits in food packaging.
It advances food-as-medicine research and public understanding of dietary risks.
Cautiously supportive with reservations.
The bill's research and advisory expansions are sensible, but implementation, costs, and trade-secret management need clear guardrails.
Seeks balance between public health benefits and regulatory burden on businesses.
Skeptical to opposed.
The bill expands FDA authority over foods, increases regulatory reach into recipes and nonlabeled ingredients, and creates new reporting and research powers that could burden businesses and erode proprietary protections.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Moderate-scope administrative fixes and research funding could clear committee, but mandatory recipe disclosures and funding needs lower enactment chance.
The bill has not accumulated any surfaced votes yet.
Recordkeeping and disclosure of recipes versus trade-secret protections
Moderate-scope administrative fixes and research funding could clear committee, but mandatory recipe disclosures and funding needs lower en…
Relative to its intended legislative type, this bill is a substantive policy change that combines statutory amendments, program creation, and new operational duties for the FDA. It provides several concrete mechanisms (…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.